<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput xmlns:ns2="local"><SourceId>1103923</SourceId><Description>Other Publication</Description><Title>A phase I dose-escalation study of the Hsp90 inhibitor STA-9090 administered once weekly in patients with solid tumors</Title><Authors><Author>Goldman JW</Author><Author>Raju RN</Author><Author>Gordon GA</Author><Author>Vukovic VM</Author><Author>Bradley R</Author><Author>Rosen LS</Author></Authors><Origin>American Society of Clinical Oncology Annual Meeting</Origin><PublicationDetails><Issue>June 5</Issue><Volume>46</Volume><Year>2010</Year></PublicationDetails><isConferencePresentation>Yes</isConferencePresentation></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput>